Direct Bilirubin

Enzymatic Method, Bilirubin

RANDOX LABORATORIES LIMITED

The following data is part of a premarket notification filed by Randox Laboratories Limited with the FDA for Direct Bilirubin.

Pre-market Notification Details

Device IDK152343
510k NumberK152343
Device Name:Direct Bilirubin
ClassificationEnzymatic Method, Bilirubin
Applicant RANDOX LABORATORIES LIMITED 55 DIAMOND ROAD, CRUMLIN County Antrim,  GB Bt29 4qy
ContactPauline Armstrong
CorrespondentPauline Armstrong
RANDOX LABORATORIES LIMITED 55 DIAMOND ROAD, CRUMLIN County Antrim,  GB Bt29 4qy
Product CodeJFM  
CFR Regulation Number862.1110 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2015-08-19
Decision Date2016-02-16
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
05055273208320 K152343 000
05055273208313 K152343 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.